Physician profile
Daniel P Conroy
NPI 1629098603
$1,967.14
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $255 · 2021: $566 · 2022: $162 · 2023: $441 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $280.28 | 2023 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $253.90 | 2019-2025 | |
| Boston Scientific Corporation | $246.23 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.94 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $183.25 | 2019-2023 | Eliquis |
| Novo Nordisk INC | $182.58 | 2021-2023 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $159.57 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $104.71 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $80.15 | 2021 | |
| Pfizer INC. | $68.61 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $63.80 | 2019-2022 | |
| Shockwave Medical, INC | $46.17 | 2025 | |
| Althera Pharmaceuticals LLC | $15.96 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| G Medical Diagnostic Services, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Conroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.